Concentration of hs-Troponin in small cohort of transgender patients

Clinica Chimica Acta - Tập 539 - Trang 66-69 - 2023
Stephen Boone1, W. Frank Peacock1, Alan H.B. Wu2, Allan Jaffe3, Robert H. Christenson4, Frederic M. Ettner5, Shahriar Dadkhah6
1Emergency Medicine, Baylor College of Medicine, Ben Taub General Hospital, Department of Emergency Medicine, 1504 Taub Loop, Houston, TX 77021, USA
2Laboratory Medicine, Chief, Clinical Chemistry Laboratory, SFGH, Chief, Clinical Pharmacogenomics Laboratory, UCSF. Zuckerberg San Francisco General Hospital, 1001 Potrero Avenue, Room 2M27, San Francisco, CA 94110, USA
3Cardiology, Professor of Laboratory Medicine and Pathology, Mayo Clinic, Gonda Building 5th Floor, 200 First St. S.W., Rochester, MN 55905, USA
4Professor of Pathology, Professor of Medical and Research Technology. University of Maryland School of Medicine, Medical Director of Core Laboratories, Medical Director of Point of Care Services, University of Maryland Medical Center, College Park, MD, USA
5Family Medicine, Department of Family Medicine, University of Chicago Pritzker School of Medicine, 7126 N. Lincoln Avenue, Lincolnwood, IL 60712, USA
6Clinical Professor of Medicine, University of Illinois at Chicago, 7126 N. Lincoln Ave, Lincolnwood, IL 60712, USA

Tài liệu tham khảo

Thygesen, 2018, Fourth Universal Definition of Myocardial Infarction (2018), Circulation, 138, e618, 10.1161/CIR.0000000000000617 Gulati, 2021, 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines, Circulation, 144, e368 Lobo, 2021, Sex-specific 99th percentile URLs for cardiac troponin assays-their time has come, Clin. Chem., 67, 197, 10.1093/clinchem/hvaa204 Bhatia, 2020, Highly sensitive cardiac troponins: the evidence behind sex-specific cutoffs, J. Am. Heart Assoc., 9, e015272, 10.1161/JAHA.119.015272 Apple, 2017, Cardiac troponin assays: guide to understanding analytical characteristics and their impact on clinical care, Clin. Chem., 63, 73, 10.1373/clinchem.2016.255109 Cheung, 2021, Approach to interpreting common laboratory pathology tests in transgender individuals, J. Clin. Endocrinol. Metab., 106, 893, 10.1210/clinem/dgaa546 Safer, 2019, Care of transgender persons, N. Engl. J. Med., 381, 2451, 10.1056/NEJMcp1903650 M. Chalabi, Why We Don’t Know The Size Of The Transgender Population, Fivethirtyeight.com. July 29, 2014, https://fivethirtyeight.com/features/why-we-dont-know-the-size-of-the-transgender-population. Accessed 7/11/2022. Zucker, 2017, Epidemiology of gender dysphoria and transgender identity, Sex Health, 14, 404, 10.1071/SH17067 Åhs, 2018, Proportion of adults in the general population of Stockholm County who want gender affirming medical treatment, PLoS One, 13, e020460, 10.1371/journal.pone.0204606 Klaver, 2018, Changes in regional body fat, lean body mass and body shape in trans persons using cross-sex hormonal therapy: results from a multicenter prospective study, Eur. J. Endocrinol., 178, 163, 10.1530/EJE-17-0496 Van Caenegem, 2015, Body composition, bone turnover, and bone mass in trans men during testosterone treatment: 1-year follow-up data from a prospective case-controlled study (ENIGI), Eur. J. Endocrinol., 172, 163, 10.1530/EJE-14-0586 T’Sjoen, 2020, European society for sexual medicine position statement “Assessment and Hormonal Management in Adolescent and Adult Trans People, With Attention for Sexual Function and Satisfaction”, J. Sex. Med., 17, 570, 10.1016/j.jsxm.2020.01.012 Cheung, 2019, Position statement on the hormonal management of adult transgender and gender diverse individuals, Med. J. Aust., 211, 127, 10.5694/mja2.50259 Hembree, 2017, Endocrine treatment of gender-dysphoric/gender-incongruent persons: an Endocrine Society Clinical Practice Guideline, J. Clin. Endocrinol. Metab., 102, 3869, 10.1210/jc.2017-01658 Fitzgerald, 2019, Analytical performance evaluation of the Elecsys® Troponin T Gen 5 STAT assay, Clin. Chim. Acta, 495, 522, 10.1016/j.cca.2019.05.026 Aakre, 2022, Analytical considerations in deriving 99th percentile upper reference limits for high-sensitivity cardiac troponin assays: educational recommendations from the IFCC Committee on Clinical Application of Cardiac Bio-Markers, Clin. Chem., 10.1093/clinchem/hvac092 Clerico, 2017, The 99th percentile of reference population for cTnI and cTnT assay: methodology, pathophysiology and clinical implications, Clin. Chem. Lab. Med., 55, 1634, 10.1515/cclm-2016-0933 Kim, 2020, Evaluation of the new Beckman Coulter Access hsTnI: 99th percentile upper reference limits according to age and sex in the Korean population, Clin. Biochem., 79, 48, 10.1016/j.clinbiochem.2020.02.005 Lee, 2015, The distribution of Abbott high-sensitivity troponin I levels in Korean patients with chest pain, Ann. Clin. Lab. Sci., 45, 152 Greene, 2022, Distribution of high-sensitivity cardiac troponin and N-terminal pro–brain natriuretic peptide in healthy transgender people, JAMA Cardiol., 10.1001/jamacardio.2022.3299 Gore, 2014, Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay, J. Am. Coll. Cardiol., 63, 1441, 10.1016/j.jacc.2013.12.032